Oradrote-MF is a combination pharmaceutical medicine that consists of Drotaverine 80mg and Mefanamic Acid 250mg. It is built to offer symptomatic relief from pain associated with smooth muscle spasms and inflammation. This medicine provides the mix action of the antispasmodic action of drovterine with the analgesic and anti-inflammatory properties of mefanamic acid. Medicines under similar category having these strengths are used in conditions like menstrual cramps and other painful conditions that include smooth muscle spasms.
Composition
Each tablet contains:
- Drotaverine Hydrochloride – 80mg
- Mefenamic Acid – 250mg
The 80mg and 250mg combination is the pharmaceutical strength of drovaterine and mefenamic acid tablets.
How Oradrote-MF Works?
Oradrote-MF mixes the two medicines that function through different mechanisms. Drovaterine is an antispasmodic agent that assists in relaxing smooth muscles. By lowering the spasms, it can help relieve cramping and pain associated with smooth muscle contractions.
Mefenamic acid comes under the category of non-steroidal anti-inflammatory drug (NSAID) class. It assists in lowering the pain and inflammation by preventing the production of prostaglandins which are chemical mediators involved in pain and inflammation. Working together these two components can offer relief when pain is followed by muscle spasms.
Uses and Therapeutic Applications
Oradrote-MF may be prescribed for the symptomatic management of pain related to the smooth muscle spasms. Drotaverine and mefenamic acid combinations are generally used for primary and secondary dysmenorrhea (menstrual cramps) and colicky pain that includes gastrointestinal and renal along with biliary colic.
It depends on the patient’s condition whether a healthcare professional may suggest this combination when both spasm and pain are contributing to symptoms.
Benefits of Oradrote-MF
The combination of Drotaverine 80mg and Mefenamic Acid 250mg offers complementary therapeutic actions:
- Helps relieve pain associated with muscle spasms.
- Supports relief from menstrual cramps.
- Helps reduce pain and inflammation.
- Provides antispasmodic and analgesic activity in a single formulation.
- May be useful in selected colicky pain conditions when prescribed by a healthcare professional.
Dosage and Administration
Oradrote-MF should be taken only according to the dosage and duration prescribed by a qualified healthcare professional. Combination products containing these ingredients are generally intended for oral administration and may be recommended with or after food to improve gastrointestinal tolerability. Do not exceed the prescribed dose or use the medicine for longer than recommended.
Safety Information
Patients should inform their doctor about any history of stomach ulcers or gastrointestinal bleeding, kidney or liver problems, heart conditions, asthma, or allergy to NSAIDs before using this medicine. Mefenamic acid can cause gastrointestinal and other NSAID-related adverse effects, while drotaverine has its own contraindications and precautions.
Oradrote-MF should not be self-medicated, particularly during pregnancy, breastfeeding, or when the patient is taking other painkillers or medicines that may interact with NSAIDs. Seek medical attention if severe abdominal pain, gastrointestinal bleeding, allergic reactions, breathing difficulty, or other serious symptoms occur.
Conclusion
Oradrote-MF, containing Drotaverine 80mg + Mefenamic Acid 250mg, is a combination formulation intended to address pain where smooth-muscle spasms and inflammation are involved. Its dual action combines an antispasmodic with an NSAID, making the formulation suitable for selected conditions such as menstrual cramps and colicky pain when prescribed appropriately.
